Visningssätt för begreppens/termernas förhållanden:
Det sätt begreppsrelationer visas:
Det sätt begreppsrelationer visas:
Kliniska prövningar, fas III
Hierarki: | ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas III 5 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas III 5 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas III 5 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas III 5 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas III 5 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas III 5 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas III 5 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas III 5 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas III 5 sidobegrepp∟ ∟ ∟ ∟ ∟ |
Bredare villkor: | ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas III ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas III ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas III ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas III ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas III ∟ ∟ ∟ ∟ Kliniska prövningar, fas III ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas III ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas III ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas III |
Anmärkning: | Clinical Trials (1980-1992)X |
Anmärkning: | Comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries.
X |
Annotation: | trial lasts about 3 years; for U.S. & foreign studies; for II/III clin trials, index under CLINICAL TRIALS, PHASE II + CLINICAL TRIALS, PHASE III; IM for articles & books about phase III clin trials as a method in med research; do not confuse with Publication Type CLINICAL TRIAL, PHASE III; DF: CLIN TRIALS PHASE III
X |
historyNote*: | 93; DRUG EVALUATION, FDA PHASE III was see CLINICAL TRIALS 1980-92; EVALUATION STUDIES, FDA PHASE III was see CLINICAL TRIALS 1982-92
X |
onlineNote*: | use CLINICAL TRIALS to search DRUG EVALUATION, FDA PHASE III 1980-92 & EVALUATION STUDIES, FDA PHASE III 1982-92
X |
publicMeSHNote*: | 93; DRUG EVALUATION, FDA PHASE III was see CLINICAL TRIALS 1980-92; EVALUATION STUDIES, FDA PHASE III was see CLINICAL TRIALS 1982-92
X |
activeMeSHYear*: | 2007X |
dateCreated*: | 1992-05-13X |
dateEstablished*: | 1993-01-01X |
dateRevised*: | 2006-07-05X |
recordAuthorizer*: | sjnX |
recordMaintainer*: | lktX |
recordOriginator*: | TPWX |
Typ: | |
Samordna villkor: | |
URI: | |
Termer och motsvarande begrepp: | Kliiniset kokeet, vaihe III (fi) XKliininen koe, vaihe III (fi, ersatt) Vaiheen III kliininen koe (fi, ersatt) Vaiheen III kliiniset kokeet (fi, ersatt) Clinical Trials, Phase III (en) Phase III Clinical Trials (en, ersatt) Phase 3 Clinical Trials (en, ersatt) Drug Evaluation, FDA Phase 3 (en, ersatt) Drug Evaluation, FDA Phase III (en, ersatt) Evaluation Studies, FDA Phase 3 (en, ersatt) Clinical Trials, Phase 3 (en, ersatt) |
Dela: |
Laddar resultat...